UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE

Cohen, H; Hunt, B; Efythymiou, M; Arachchillage, D; Ruiz, M; Clawson, S; Muirhead, N; ... Collaborators, RAPST; + view all (2015) Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Journal of Thrombosis and Haemostasis , 13 , Article LB003. 10.1111/jth.12993. Green open access

[img]
Preview
Text
Cohen_1463884_RAPS_protocol_paper_V2.0_26Feb2015 - Appendices(red).pdf

Download (424kB) | Preview
Type: Article
Title: Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/jth.12993
Publisher version: http://dx.doi.org/10.1111/jth.12993
Language: English
Additional information: Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. This is the peer reviewed version of the following article: Cohen, H; Hunt, B; Efythymiou, M; Arachchillage, D; Ruiz, M; Clawson, S; Muirhead, N; (2015) Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Journal of Thrombosis and Haemostasis , 13 , Article LB003, which has been published in final form at http://dx.doi.org/10.1111/jth.12993. After an initial embargo period, this article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Keywords: Antiphospholipid syndrome; systemic lupus erythematosus; venous thromboembolism; rivaroxaban; warfarin; thrombin generation
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Institute of Prion Diseases
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Institute of Prion Diseases > UCL Institute of Prion Diseases Support
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Inst of Clinical Trials and Methodology > Comprehensive CTU at UCL
URI: http://discovery.ucl.ac.uk/id/eprint/1463884
Downloads since deposit
64Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item